Article Details

Astellas' XOSPATA® (gilteritinib) Receives Conditional Approval by China's National Medical ...

Retrieved on: 2021-02-04 03:00:00

Tags for this article:

Click the tags to see associated articles and topics

Astellas' XOSPATA® (gilteritinib) Receives Conditional Approval by China's National Medical .... View article details on hiswai:

Excerpt

... Director of Institute of Hematology, Chinese Academy of Medical Sciences. ... of healthcare change to turn innovative science into value for patients.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up